| Identification | Back Directory | [Name]
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, hydrochloride (1:4), (αS,α′S,α′′S,3R,3′R,3′′R)- | [CAS]
2565656-71-3 | [Synonyms]
Muvalaplin (tetrahydrochloride)
3-Pyrrolidineacetic acid, α,α′,α′′-[nitrilotris(methylene-3,1-phenylenemethylene)]tris-, hydrochloride (1:4), (αS,α′S,α′′S,3R,3′R,3′′R)- | [Molecular Formula]
C42H54N4O6.4ClH | [MOL File]
2565656-71-3.mol | [Molecular Weight]
856.75 |
| Hazard Information | Back Directory | [Uses]
Muvalaplin tetrahydrochloride (LY3473329) is an orally active reagent of lipoprotein (a) (Lp (a)). At present, research on Muvalaplin tetrahydrochloride oral reagent is ongoing[1]. | [References]
[1] Bhatia HS, et al. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13;11(20):6040. DOI:10.3390/jcm11206040 |
|
|